I agree with Surges. Timelines on various studies are getting closer, Annct of new candidates getting closer, CNS area closer to being advised, US activity can’t be for no reason, healthcare chat’s, , the list goes on.
Anyone who sells before all these items drop is banking on failure, but at these prices failure is already baked in. Close to 3-4 drugs in orphan area and it could be worth 1-2B US before they get to the clinic.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)